Latest Advisory

  • FDA Advisory No. 2017-212 || Public Health Warning Against the Purchase and Use of Unregistered Health Related Device (Water Purification Device) “Biocera Alkaline Antioxidant Stick”

    FDA Advisory No. 2017-212 || Public Health Warning Against the Purchase and Use of Unregistered Health Related Device (Water Purification Device) “Biocera Alkaline Antioxidant Stick”

    Read more

  • DOH Message on the occassion of 2nd SONA

    DOH Message on the occassion of 2nd SONA

    Read more

  • FDA Advisory No. 2017-211 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 59)

    FDA Advisory No. 2017-211 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 59)

    Read more

  • FDA Advisory No. 2017-207 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 55)

    FDA Advisory No. 2017-207 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 55)

    Read more

  • FDA Advisory No. 2017-186 || Voluntary Recall of Cobra Distal Radius Fixator, with DVR-5258

    FDA Advisory No. 2017-186 || Voluntary Recall of Cobra Distal Radius Fixator, with DVR-5258

    Read more

  • FDA DG PUNO WITH WHO RP REP

    FDA DG PUNO WITH WHO RP REP

    Read more

  • FDA Advisory No. 2017-203 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    FDA Advisory No. 2017-203 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    Read more

  • FDA Advisory No. 2017-206 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “Fresenius Optiflux F180NR Dialyzer”

    FDA Advisory No. 2017-206 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “Fresenius Optiflux F180NR Dialyzer”

    Read more

  • FDA Advisory No. 2017-205 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “Stay Fresh Anion Premium Pantyliner”

    FDA Advisory No. 2017-205 || Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Product “Stay Fresh Anion Premium Pantyliner”

    Read more

  • FDA Advisory No. 2017-202 ||Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 61)

    FDA Advisory No. 2017-202 ||Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 61)

    Read more

  • FDA Advisory No. 2017-201 ||Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 57)

    FDA Advisory No. 2017-201 ||Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 57)

    Read more

  • FDA Advisory No. 2017-200 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 56)

    FDA Advisory No. 2017-200 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 56)

    Read more

  • FDA Advisory No. 2017-199 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 14)

    FDA Advisory No. 2017-199 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 14)

    Read more

  • FDA Advisory No. 2017-198 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 3)

    FDA Advisory No. 2017-198 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 3)

    Read more

  • FDA Advisory No. 2017-197 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 58)

    FDA Advisory No. 2017-197 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 58)

    Read more

  • FDA Advisory No. 2017-196 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 53)

    FDA Advisory No. 2017-196 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 53)

    Read more

  • FDA Advisory No. 2017-195 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 52)

    FDA Advisory No. 2017-195 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 52)

    Read more

  • FDA Advisory No. 2017-194 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 48)

    FDA Advisory No. 2017-194 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 48)

    Read more

  • FDA Advisory No. 2017-191 || Safety Issues of Talc-Containing Body Powder Used in the Perineal Area of the Body

    FDA Advisory No. 2017-191 || Safety Issues of Talc-Containing Body Powder Used in the Perineal Area of the Body

    Read more

  • FDA Advisory No. 2017-190 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 47)

    FDA Advisory No. 2017-190 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 47)

    Read more

NOTICE OF RELOCATION

We are pleased to announce that effective on 13-July 2017 Food and Drug Administration Regional Field Office – XI (FDA RFO-XI) will be relocated at:

Food and Drug Administration Regional Field Office – XI (FDA RFO-XI)

#31 2nd Floor, LCI Building,
Quimpo Boulevard, Ecoland,
Davao City

Contact Number: (082) 273-2445

 

 

RELOCATION AND OPERATION OF FDAC AT THE 4TH FLOOR, CIVIC PRIME BUILDING, CIVIC DRIVE, FILINVEST CORPORATE CITY, ALABANG,  MUNTINLUPA CITY STARTING 24 JULY 2017 (MONDAY)

In connection to the FDA Advisory No. 2017-204 titled “Relocation of the Food and Drug Action Center (FDAC)”, all transactions in the FDA PAIR Unit at Room 106 will be entertained at new FDAC Office located at Civic Prime Bldg., Civic Drive, Alabang Muntinlupa City, starting on Monday, July 24, 2017.

For your information, guidance and compliance.

Attachments:
Download this file (FDAC- Announcement.pdf)FDAC- Announcement.pdf

Submission of Comments on Draft Policies by the Center for Food Regulation and Research Extended

Please be informed that the Center for Food Regulation and Research (CFRR) has extended the period for submission of comments on the updated draft regulatory policies:

Title:

Recipient’s email address:

Due date:

A.    Draft Administrative Order - Revised Regulatory Guidelines Concerning Food Additives and Processing Aids

This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it.

Cc:  This email address is being protected from spambots. You need JavaScript enabled to view it.

July 31, 2017

 

B.     Draft Administrative - Order Adoption of all Philippine National Standards (PNS) Approved and Issued by the FDA and Other Standards as Technical Regulation

This email address is being protected from spambots. You need JavaScript enabled to view it.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Cc:  This email address is being protected from spambots. You need JavaScript enabled to view it.

August 13, 2017

C.     Draft FDA Circular - Rules and Guidelines on the Rules and Guidelines on the Issuance of Import Permit as “Samples Only” for FDA Regulated Products Intended for Research and Development Purposes

This email address is being protected from spambots. You need JavaScript enabled to view it.

Cc:  This email address is being protected from spambots. You need JavaScript enabled to view it.

 

August 13, 2017

For your information and guidance.

 

Thank you.

FDA Memorandum Circular No. 2017-002

1st Food and Drug Administration (FDA) Regulatory Advocacy Fair and Back-to-back Qualified Person in the Industry Regulatory Affairs (QPIRA) Trainings

I. BACKGROUND

The Food and Drug Administration will hold the 1st FDA Regulatory Advocacy Fair coinciding its 54 years as health product regulator. Timely with the celebration, FDA will be holding activities which not only showcase the Agency’s milestones but extend its services to valued stakeholders. One of the main activities is the Qualified Person in the Industry Regulatory Affairs (QPIRA) training. In this event, subject to rules and guidelines that will be strictly implemented, FDA will have an avenue to promote awareness and learning for its stakeholders, to showcase industry best practices, professional organization membership, regulatory affairs success stories; quality management programs, good manufacturing practices, product safety projects, and anti-counterfeit programs, and the like. With corresponding fees and charges, booths will be opened for Stakeholder Organizations strongly promoting the Agency’s advocacies as mentioned as a way to enhance stakeholder engagement and learning.

Attachments:
Download this file (FMC2017-002.pdf)FMC2017-002.pdf

No Transaction at Policy Planning Service and FDA Academy on 26 - 28 July 2017

A three-day Operational Planning Seminar-Workshop will be conducted by the Policy and Planning Services and FDA Academy on 26-28 July 2017 in Batangas for all its current and Newly hired employees. This workshop aims to define the strategies that PPS will employ in implement the FDA Strategic Plan, ultimately aiming to refine relevant policies and process for the improvement of services.

In view of this there will be no transactions at the Policy and Planning Service and FDA Academy on 26 - 28 July 2017. All related transactions will resume on 31 July 2017.

 

Thank you for your understanding.

 

 

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter